Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
doi: 10.1016/S0140-6736(19)32517-6 Summary Keywords non-alcoholic steatohepatitis, nonalcoholic fatty liver disease, obesity, insulin resistance, metabolic syndrome, metabolic disease, fibroblast growth factor 21 Citation Tillman EJ and Rolph T (2020) FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
M.NassR.LopesB.LawsE
20 GojkovicS.KrezicI.VranesH.ZizekH.DrmicD.Horvat PavlovK.et al (2021a)
5-amino-1mq successfully inhibits NNMT in cell cultures and animal models
Speeds Up Healing Processes : Due to its role in cellular regeneration, IGF-1 LR3 may also reduce recovery times from injuries and illnesses
US$ 28.85
US$ 27.75
US$ 27.02
US$ 21.43
